|
RNF7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.278390E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.460400E-03 |
| Normal-vs-Stage2 |
2.393600E-02 |
| Normal-vs-Stage3 |
2.787000E-01 |
| Normal-vs-Stage4 |
5.720200E-01 |
| Stage1-vs-Stage2 |
5.136400E-01 |
| Stage1-vs-Stage3 |
1.093780E-01 |
| Stage1-vs-Stage4 |
2.184100E-03 |
| Stage2-vs-Stage3 |
9.774000E-02 |
| Stage2-vs-Stage4 |
1.187540E-02 |
| Stage3-vs-Stage4 |
1.530170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.411700E-02 |
| Normal-vs-AfricanAmerican |
1.640200E-01 |
| Normal-vs-Asian |
1.308450E-01 |
| Caucasian-vs-AfricanAmerican |
8.463600E-01 |
| Caucasian-vs-Asian |
8.910000E-01 |
| AfricanAmerican-vs-Asian |
9.283800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.175900E-02 |
| Normal-vs-Female |
1.076080E-02 |
| Male-vs-Female |
5.425800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.637400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.321900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.081000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.097600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.232000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.855580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.716600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.953800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.000000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.530800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.237700E-02 |
| Classical-VS-Follicular |
6.612100E-02 |
| Classical-VS-Other |
2.168000E-01 |
| Classical-VS-Normal |
2.501500E-02 |
| Tall-VS-Follicular |
1.156730E-03 |
| Tall-VS-Other |
1.325890E-02 |
| Tall-VS-Normal |
4.288400E-01 |
| Follicular-VS-Other |
7.837000E-01 |
| Follicular-VS-Normal |
2.402400E-03 |
| Other-VS-Normal |
1.495760E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.779700E-03 |
| Normal-vs-N1 |
8.928600E-01 |
| N0-vs-N1 |
7.415300E-03 |
|
|
